India's Eris Lifesciences launches generic semaglutide at $13.8 per month
Go back to India's Eris Lifesciences launches generic semaglutide at $13.8 per month| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1107.08 +5.00 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1102.08 | 52 Week High | $88.16 | |||
| Open | $1117.00 | 52 Week Low | $67.88 | |||
| Day High | $1122.02 | P/E | 256.27 | |||
| Day Low | $1079.22 | EPS | $4.32 | |||
| Volume | 3,314,672 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 47.42 +1.54 (3.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.88 | 52 Week High | $59.00 | |||
| Open | $46.80 | 52 Week Low | $32.80 | |||
| Day High | $47.43 | P/E | N/A | |||
| Day Low | $46.44 | EPS | $0.00 | |||
| Volume | 20,222,572 | |||||
